Clinical Trials Browser

Oropharyngeal Neoplasms × balstilimab × 90 days × Clear all

NCT05363709 2026-05-12

BALSTILIMAB on Viral Clearance in HPV+ Oropharyngeal Cancer Patients

Phase 2 Withdrawn

Oropharyngeal Neoplasms